FGFR2‐RUNX2 activation: An unexplored therapeutic pathway in luminal breast cancer related to tumor progression
Sign Up to like & getrecommendations! Published in 2024 at "International Journal of Cancer"
DOI: 10.1002/ijc.35302
Abstract: Overcoming luminal breast cancer (BrCa) progression remains a critical challenge for improved overall patient survival. RUNX2 has emerged as a protein related to aggressiveness in triple‐negative BrCa, however its role in luminal tumors remains elusive.… read more here.
Keywords: brca; progression; fgfr2 runx2; tumor ... See more keywords